|
DIS3L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.43138842392909E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63391522534084E-12 |
| Normal-vs-Stage2 |
1.9906399999936E-05 |
| Normal-vs-Stage3 |
2.18829999999448E-05 |
| Normal-vs-Stage4 |
8.416300E-04 |
| Stage1-vs-Stage2 |
4.789000E-01 |
| Stage1-vs-Stage3 |
4.113800E-01 |
| Stage1-vs-Stage4 |
7.014400E-01 |
| Stage2-vs-Stage3 |
9.826000E-01 |
| Stage2-vs-Stage4 |
3.770000E-01 |
| Stage3-vs-Stage4 |
4.142400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77635683940025E-15 |
| Normal-vs-AfricanAmerican |
2.3600999998763E-07 |
| Normal-vs-Asian |
5.163400E-03 |
| Caucasian-vs-AfricanAmerican |
7.409900E-02 |
| Caucasian-vs-Asian |
2.985000E-01 |
| AfricanAmerican-vs-Asian |
7.343200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
6.38379999999827E-05 |
| Male-vs-Female |
3.69500000000356E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.32540000050841E-07 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.63980051759438E-10 |
| Normal-vs-Extreme_Obese |
2.056200E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.286200E-02 |
| Normal_Weight-vs-Obese |
9.968600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.002000E-01 |
| Extreme_Weight-vs-Obese |
2.283700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.955200E-01 |
| Obese-vs-Extreme_Obese |
3.831400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.603100E-04 |
| Normal-vs-Age(41-60Yrs) |
3.38710171021717E-11 |
| Normal-vs-Age(61-80Yrs) |
1.33226762955019E-15 |
| Normal-vs-Age(81-100Yrs) |
3.199400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.554600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.145200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.723200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.416000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.776570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.264400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.88178419700125E-16 |
| Normal-VS-Type2 PRCC |
4.55960047496262E-10 |
| Normal-VS-KIRP CIMP |
2.11290000051712E-07 |
| Normal-VS-Unclassified PRCC |
4.07199999999941E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.491400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.286600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.206400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.066200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.998800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.211400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.87583282240666E-12 |
| Normal-vs-N1 |
1.699250E-03 |
| Normal-vs-N2 |
3.05429999958307E-07 |
| N0-vs-N1 |
4.641500E-02 |
| N0-vs-N2 |
3.303400E-01 |
| N1-vs-N2 |
1.304780E-01 |
|
|
